Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs.
about
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec.Antioxidant/Prooxidant and antibacterial/probacterial effects of a grape seed extract in complex with lipoxygenase.Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings.Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?Resistant plasmid profile analysis of multidrug resistant Escherichia coli isolated from urinary tract infections in Abeokuta, Nigeria.Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.Pattern of Antibiotic Resistance Among Community Derived Isolates of Enterobacteriaceae Using Urine Sample: A Study From Northern India.The treatment of urinary tract infections and use of ciprofloxacin extended release.Non-prescription antimicrobial use worldwide: a systematic reviewAmpicillin resistance and outcome differences in acute antepartum pyelonephritis.Differences in antimicrobial susceptibility in Escherichia coli from Canadian intensive care units based on regional and demographic variables.The importance and future of antimicrobial surveillance studies.Antimicrobial resistance 1979-2009 at Karolinska hospital, Sweden: normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Antimicrobial resistance patterns in Enterobacteriaceae isolated from an urban wastewater treatment plant.Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid.National surveillance of antimicrobial susceptibility of CTX-M-positive and -negative clinical isolates of Escherichia coli from Kuwait government hospitals.Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007.Surveillance of antimicrobial resistance in resource-constrained settings - experience from five pilot projects.Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from human stools and drinking water sources in Jordan.An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.Low level of antimicrobial resistance in Escherichia coli among Swedish nursing home residents.
P2860
Q30447051-6FF65161-30EC-4304-91E4-18CA2778AD34Q33314977-4381C877-328F-4DBF-8534-110718292915Q33593668-E574FCE2-7DEF-489C-B8CB-99A610B74F47Q34275416-3FC4C91D-4DC6-4F6B-A973-7F7308EDC09EQ34341884-16E53624-E2FE-4BC3-8C88-C0630FD531B7Q35205848-BAC09429-2AB7-4D98-B85A-77F842DFC08CQ35207138-D3BD82D5-B6E8-4672-B952-8C62047D46FBQ36035185-EE247948-5B2B-4DE7-9E30-9CC90BEA3DFEQ36068132-7AF02FCD-F74A-4BBD-9E06-711B14D23FE1Q36458378-24B36340-A09A-45C9-AFA0-1D2C1D88CA18Q36529047-E46C2B89-F79F-4823-A2A8-DDF289CF031FQ36932303-2B355F06-CF7A-425D-9E50-A57BC9EF57EFQ37018234-57305904-A1B4-4157-9462-CCCC78AB2257Q37247114-F17C2A4F-BF90-4DAB-8B2F-5739DF9D93C8Q37780780-4E5B2E28-7677-40CC-A73B-D20AE0E821AFQ37998398-0F8B3F79-CC3D-4960-AAE9-E67BC2512974Q39783381-A805F61B-129E-461A-A6CA-38F340681B2EQ41909283-666FB78C-623F-4A75-B5BA-0023A3145B74Q42946338-54DC5A30-8F59-4D85-926B-2D8ECD7C5638Q43219801-E8C27313-69F5-48C2-8574-3B911D560FB7Q46796129-12C25F8D-69BA-407B-AF5A-AC379979785FQ51100474-2E663AD5-6B65-41DB-812C-C5C11D0E4D1AQ53703982-C8100A62-64F0-44EC-9146-B971E28100ABQ54327524-9DAF1F91-119C-4B5C-8857-956AEF5F3A41
P2860
Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Integrating Escherichia coli a ...... ultiple surveillance programs.
@ast
Integrating Escherichia coli a ...... ultiple surveillance programs.
@en
type
label
Integrating Escherichia coli a ...... ultiple surveillance programs.
@ast
Integrating Escherichia coli a ...... ultiple surveillance programs.
@en
prefLabel
Integrating Escherichia coli a ...... ultiple surveillance programs.
@ast
Integrating Escherichia coli a ...... ultiple surveillance programs.
@en
P2093
P2860
P356
P1476
Integrating Escherichia coli a ...... ultiple surveillance programs.
@en
P2093
John M Stelling
Karin Travers
Philip J Turner
Ronald N Jones
Stuart B Levy
Thomas F O'Brien
P2860
P304
P356
10.3201/EID1106.041160
P577
2005-06-01T00:00:00Z